Plasma homocysteine and l-dopa metabolism in patients with Parkinson disease.

نویسندگان

  • F Blandini
  • R Fancellu
  • E Martignoni
  • A Mangiagalli
  • C Pacchetti
  • A Samuele
  • G Nappi
چکیده

tients with Parkinson Disease, Fabio Blandini, Roberto Fancellu, Emilia Martignoni, Anna Mangiagalli, Claudio Pacchetti, Alberta Samuele, and Giuseppe Nappi ( Laboratory of Functional Neurochemistry, 2 Center for Parkinson Disease and Movement Disorders, Neurological Institute “C. Mondino”, 27100 Pavia, Italy; 3 University of Insubria, 21100 Varese, Italy; 4 University of Piemonte Orientale “Amedeo Avogadro”, 28100 Novara, Italy; 5 Institute of Nervous and Mental Diseases, University of Rome “La Sapienza”, 00185 Rome, Italy; * address correspondence to this author at: Laboratory of Functional Neurochemistry, Neurological Institute “C. Mondino”, Via Palestro, 3 27100 Pavia, Italy; fax 39-0382-380286, e-mail [email protected])

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Methylation demand: a key determinant of homocysteine metabolism.

Elevated plasma homocysteine is a risk factor for cardiovascular disease and Alzheimer's disease. To understand the factors that determine the plasma homocysteine level it is necessary to appreciate the processes that produce homocysteine and those that remove it. Homocysteine is produced as a result of methylation reactions. Of the many methyltransferases, two are, normally, of the greatest qu...

متن کامل

Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration.

BACKGROUND Levodopa metabolism via catechol O-methyltransferase increases levels of the neurotoxin homocysteine, which induces an axonal-accentuated degeneration in sensory peripheral nerves in vitro. OBJECTIVES To demonstrate associations among daily levodopa/dopa decarboxylase inhibitor intake, total homocysteine plasma (tHcy) levels, and electrophysiologic sural nerve conduction findings. ...

متن کامل

Early outcome of subthalamic nucleus deep brain stimulation (STN-DBS) in advanced parkinson disease in first trial of Iranian patients

  Abstract   Background: To improve the debilitating features of Parkinson disease (PD) different   medical and surgical approaches are available. Subthalamic nucleus deep brain   stimulation (STN-DBS) was appeared to be a promising method during last two   decades. This study aimed to evaluate early motor outcomes of this procedure in first   trial of Iranian patients .   Methods: Thirty-seven...

متن کامل

Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications.

OBJECTIVE To determine whether plasma homocysteine (Hcy) levels are associated with clinical characteristics, neuropsychological and psychiatric manifestations and cardiovascular comorbidity in patients with Parkinson disease (PD). BACKGROUND Elevated Hcy levels are linked to atherosclerosis, vascular disease, depression, and dementia. Patients with PD treated with L-dopa have been shown to h...

متن کامل

رابطه بین هموسیستیین پلاسما و فشار خون در بیماران مبتلا به دیابت نوع دو

Background: Hyperhomocysteinemia may increase blood pressure by inducing endothelial cells dysfunction . The aim of this study was determining the relationship between plasma Homocysteine (Hcy) levels and blood pressure in new cases of type 2 diabetes mellitus.Methods: As a cross sectional study, 46 new cases of type 2 diabetes mellitus referred to Isfahan Endocrine and Metabolism Research Cent...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Clinical chemistry

دوره 47 6  شماره 

صفحات  -

تاریخ انتشار 2001